logo
Plus   Neg
Share
Email

Iamgold Receives Additional Warrants In Galane Gold - Quick Facts

Iamgold Corp. (IAG, IMG.TO) announced that it has received an additional 3.11 million warrants to purchase an equivalent number of common shares of Galane Gold Ltd. (GG.V) pursuant to that agreement by which Galane, indirectly, acquired ownership of the Mupane gold mine in Botswana, Africa from Iamgold.

The receipt of these additional warrants was contemplated in the original agreement upon Galane's completion of its acquisition of Northern Lights Exploration Company Pty. Ltd.

IAMGOLD's ownership of 26.25 million common shares of Galane maintains its approximate 49.9% interest in Galane's outstanding common shares.

Iamgold noted that the warrants to purchase common shares of Galane received today by the company are for investment purposes. Iamgold said it does not have any present intention to acquire ownership of, or control or direction over, additional securities of Galane.

Iamgold said that its the intention is to evaluate its investment in Galane on a continuing basis and such holdings may be increased or decreased in the future.

by RTTNews Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Quick Facts

Editors Pick
In the age of social media, it takes mere hours for a company to suffer the backlash of of allegations of racism. For some companies, these incidents have hurt their bottom line and sullied their reputations. For others, they were a blip caused by clumsy if not altogether coincidental missteps. In... BJ's Wholesale Club Holdings Inc., which is planning a return to the public market, has set terms for its planned initial public offering or IPO. In a filing with the U.S. Securities and Exchange Commission, the warehouse club operator said Monday that it plans to offer 37.5 million shares priced between $15 and $17 per share. At the top end of the range, the offering would raise $637.5 million. Shares of Valeant Pharmaceuticals International Inc. are falling more than 6 percent in Monday's trading following news that the U.S. Food and Drug Administration has failed to approve the Canada-based company's Duobrii lotion for the treatment of plaque psoriasis. Ortho Dermatologics, a division of Valeant Pharmaceuticals, said it has received a Complete Response Letter or CRL from the FDA.
Follow RTT